Skip to content

Study on effects of banana intake and intake time on blood glucose levels and spike.

Study on effects of banana intake and intake time on blood glucose levels and spike. - Study on effects of banana intake and intake time on blood glucose levels and spike.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050025
Enrollment
54
Registered
2023-01-13
Start date
2023-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Ingest approximately 120 g of bananas edible portion at the beginning of breakfast every day for 2 weeks. Ingest approximately 120 g of bananas edible portion at the end of dinner every day for 2 week

Sponsors

Akasaka Family Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Healthy Japanese who are 40 years old or more and under 60 years old at the time of obtaining consent 3.Persons who can wear a continuous blood glucose meter on their arm at home

Exclusion criteria

Exclusion criteria: 1.Persons who are currently suffering from some kind of disease and are judged by the investigator to need treatment 2.Persons with severe anemia 3.Pregnant, lactating, pregnant 4.Persons who may cause allergic symptoms to the ingredients contained in the test food 5.Persons with alcoholism or other mental disorders 6.Persons who have a smoking habit, those who have quit smoking for less than 10 years 7.Persons with borderline diabetes or already diagnosed diabetes, fasting blood glucose of 110 mg/dl or higher, or HbA1c of 6.5% or higher, or blood glucose of 140 mg/dl or higher in 2 hours of 75g oral glucose tolerance test 8.Persons who may change their lifestyle during the examination period (night shift, long trip, etc.) 9.Persons who may develop seasonal allergic symptoms such as pollinosis during the test period 10.Persons who plan to take new health foods and supplement foods during the examination period 11.Persons who have received hormone replacement therapy within the past 6 months 12.Persons who have been treated with hospitalization within the past 6 months 13.Persons who are scheduled for imaging tests such as X-ray, MRI, CT scan, etc. during the continuous blood glucose monitoring period. 14.Persons who participate in other clinical studies or participated in the last 3 months or plan to participate in other clinical studies. 15.Persons who have had risk in the past or are at risk for contact dermatitis. 16.Persons who are judged by the investigator to be inappropriate for this study.

Design outcomes

Primary

MeasureTime frame
Postprandial blood glucose (measured by a continuous blood glucose meter)

Secondary

MeasureTime frame
Fasting blood index (total protein, albumin, total cholesterol, LDL cholesterol, HDL cholesterol, neutral fat, urea nitrogen, creatinine, uric acid, aspartate aminotransferase(AST), alanine aminotransferase(ALT), HbA1C, glucose, glycoalbumin, 1.5AG, insulin, sodium, potassium, chlorine, calcium, magnesium, inorganic phosphorus, serum iron, blood count, ferritin) Body composition (body weight, BMI, lean body mass)

Countries

Japan

Contacts

Public ContactTakamasa Masuda

Healthcare Systems Co., Ltd. Clinical Research Department

masudat@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026